𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacological long-term treatment strategies in first episode schizophrenia

✍ Scribed by Wolfgang Gaebel; Hans-Jürgen Möller; Gerd Buchkremer; Christian Ohmann; Mathias Riesbeck; Wolfgang Wölwer; Martina Wilmsdorff; Ronald Bottlender; Stefan Klingberg


Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
312 KB
Volume
254
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Long-term treatment with long-acting ris
✍ Moon-Soo Lee; Young-Hoon Ko; Sang-Hoon Lee; Yong-Jin Seo; Seung-Hyun Kim; Sook-H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract ## Objectives We evaluated the efficacy and safety of long‐acting risperidone for 48‐week period in Korean patients. ## Methods This was a non‐randomized, open‐label, single‐centered, 48‐week study. Each of the participants visited the hospital every 2 weeks, and injections were give

Focal dystonia in musicians: Treatment s
✍ Hans-Christian Jabusch; Dorothea Zschucke; Alexander Schmidt; Stephan Schuele; E 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract We present the long‐term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexiphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patien

Influence of stent treatment strategies
✍ Manuel Pan; José Suárez de Lezo; Alfonso Medina; Miguel Romero; Sandra González; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

Diffuse coronary lesions (length > 20 mm) are still considered high risk for percutaneous intervention even in the current stent era. We compared the 2-year outcome of patients with long diffuse stenosis treated by three different stent strategies. In addition, we also analyzed the possible factors

Quetiapine is effective against anxiety
✍ Siegfried Kasper 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

This analysis of data from the open-label extension (OLE) phases of three randomized clinical trials of quetiapine in patients with schizophrenia (n=415) was undertaken to investigate whether the initial improvements in anxiety and depressive symptoms were maintained during long-term treatment. The